Y Intercept Hong Kong Ltd Grows Stake in Select Medical Holdings Corporation $SEM

Y Intercept Hong Kong Ltd lifted its stake in shares of Select Medical Holdings Corporation (NYSE:SEM) by 77.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 154,401 shares of the health services provider’s stock after purchasing an additional 67,526 shares during the period. Y Intercept Hong Kong Ltd owned 0.12% of Select Medical worth $1,983,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Advisors Asset Management Inc. grew its stake in shares of Select Medical by 13.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 7,135 shares of the health services provider’s stock worth $108,000 after acquiring an additional 834 shares during the period. Brucke Financial Inc. increased its stake in shares of Select Medical by 7.0% in the second quarter. Brucke Financial Inc. now owns 13,638 shares of the health services provider’s stock worth $207,000 after purchasing an additional 898 shares in the last quarter. Wilmington Savings Fund Society FSB raised its position in shares of Select Medical by 20.9% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after purchasing an additional 999 shares during the period. Oregon Public Employees Retirement Fund lifted its stake in shares of Select Medical by 5.1% during the 3rd quarter. Oregon Public Employees Retirement Fund now owns 24,816 shares of the health services provider’s stock valued at $319,000 after buying an additional 1,200 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in Select Medical by 15.9% in the 2nd quarter. PNC Financial Services Group Inc. now owns 8,828 shares of the health services provider’s stock worth $134,000 after buying an additional 1,208 shares during the period. 89.48% of the stock is owned by institutional investors.

Select Medical Stock Down 1.1%

SEM opened at $14.78 on Thursday. The company has a market cap of $1.83 billion, a P/E ratio of 17.19, a P/E/G ratio of 0.52 and a beta of 1.26. Select Medical Holdings Corporation has a 12 month low of $11.65 and a 12 month high of $20.37. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87. The business’s 50-day moving average price is $15.04 and its 200-day moving average price is $13.88.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.33 billion. Select Medical had a net margin of 2.05% and a return on equity of 7.41%. The company’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.43 EPS. On average, equities analysts expect that Select Medical Holdings Corporation will post 1.17 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. Mizuho set a $17.00 target price on shares of Select Medical in a report on Monday, November 3rd. Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Benchmark reaffirmed a “buy” rating on shares of Select Medical in a report on Monday, October 27th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Select Medical in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada boosted their price objective on shares of Select Medical from $16.00 to $20.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Select Medical presently has an average rating of “Moderate Buy” and a consensus price target of $17.80.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.